These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36560917)

  • 1. Correction of Anticoagulant Therapy in Patients with Severe COVID-19 Virus Infection Using a Thrombodynamics Coagulation Assay.
    Vuimo TS; Tsarenko SV; Filimonova EV; Seregina EA; Karamzin SS
    Clin Appl Thromb Hemost; 2022; 28():10760296221142862. PubMed ID: 36560917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombodynamics-A new global hemostasis assay for heparin monitoring in patients under the anticoagulant treatment.
    Balandina AN; Serebriyskiy II; Poletaev AV; Polokhov DM; Gracheva MA; Koltsova EM; Vardanyan DM; Taranenko IA; Krylov AY; Urnova ES; Lobastov KV; Chernyakov AV; Shulutko EM; Momot AP; Shulutko AM; Ataullakhanov FI
    PLoS One; 2018; 13(6):e0199900. PubMed ID: 29953528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integral assays of hemostasis in hospitalized patients with COVID-19 on admission and during heparin thromboprophylaxis.
    Bulanov AY; Bulanova EL; Simarova IB; Bovt EA; Eliseeva OO; Shakhidzhanov SS; Panteleev MA; Roumiantsev AG; Ataullakhanov FI; Karamzin SS
    PLoS One; 2023; 18(6):e0282939. PubMed ID: 37267317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial.
    Busani S; Tosi M; Mighali P; Vandelli P; D'Amico R; Marietta M; Forfori F; Donati A; Cinnella G; De Monte A; Pasero D; Bellani G; Tascini C; Foti G; Ranieri M; Girardis M
    Trials; 2020 Aug; 21(1):724. PubMed ID: 32807241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ROLE OF THROMBODYNAMICS GLOBAL COAGULATION TEST IN IMPROVING TREATMENT RESULTS IN PATIENTS WITH CORONAVIRUS INFECTION AT A COVID-19 HOSPITAL.
    Krylov A; Khorobrykh T; Petrovskaya A; Khmyrova S; Agadzhanov V; Khusainova N
    Georgian Med News; 2021 Apr; (313):72-79. PubMed ID: 34103434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PO-22 - Thrombodynamics test for analysis of hemostasis in patients with malignant tumors and predicting thrombotic complications.
    Vasilenko I; Vlasova E; Metelin V; Balkanov A; Bichenkov O
    Thromb Res; 2016 Apr; 140 Suppl 1():S184. PubMed ID: 27161711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
    Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R;
    Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of the Caprini score in conjunction with thrombodynamic testing reduces the number of unpredicted postoperative venous thromboembolism events in patients with colorectal cancer.
    Lobastov K; Dementieva G; Soshitova N; Bargandzhiya A; Barinov V; Laberko L; Rodoman G
    J Vasc Surg Venous Lymphat Disord; 2020 Jan; 8(1):31-41. PubMed ID: 31495765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The laboratory control of anticoagulant thromboprophylaxis during the early postpartum period after cesarean delivery.
    Koltsova EM; Balandina AN; Grischuk KI; Shpilyuk MA; Seregina EA; Dashkevich NM; Poletaev AV; Pyregov AV; Sukhih GT; Serebriyskiy II; Ataullakhanov FI
    J Perinat Med; 2018 Apr; 46(3):251-260. PubMed ID: 28599392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
    Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
    Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic dosing of low-molecular-weight heparin may decrease mortality in patients with severe COVID-19 infection.
    Canoglu K; Saylan B
    Ann Saudi Med; 2020; 40(6):462-468. PubMed ID: 33307734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low molecular weight heparin for prevention of central venous catheter-related thrombosis in children.
    Pelland-Marcotte MC; Amiri N; Avila ML; Brandão LR
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD005982. PubMed ID: 32557627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venographic comparison of subcutaneous low-molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis.
    Gonzalez-Fajardo JA; Arreba E; Castrodeza J; Perez JL; Fernandez L; Agundez I; Mateo AM; Carrera S; Gutiérrez V; Vaquero C
    J Vasc Surg; 1999 Aug; 30(2):283-92. PubMed ID: 10436448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombodynamics, a new global coagulation test: Measurement of heparin efficiency.
    Sinauridze EI; Vuimo TA; Tarandovskiy ID; Ovsepyan RA; Surov SS; Korotina NG; Serebriyskiy II; Lutsenko MM; Sokolov AL; Ataullakhanov FI
    Talanta; 2018 Apr; 180():282-291. PubMed ID: 29332812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systems Biology Approach for Personalized Hemostasis Correction.
    Pisaryuk AS; Povalyaev NM; Poletaev AV; Shibeko AM
    J Pers Med; 2022 Nov; 12(11):. PubMed ID: 36422079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preserved clot formation detected by the Thrombodynamics analyzer in patients with cirrhosis.
    Potze W; Adelmeijer J; Porte RJ; Lisman T
    Thromb Res; 2015 May; 135(5):1012-6. PubMed ID: 25746364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory tests for coagulation system monitoring in a patient with β-thalassemia.
    Seregina EA; Nikulina OF; Tsvetaeva NV; Rodionova MN; Gribkova IV; Orel EB; Zapariy AP; Erasov AV; Balandina AN; Ananyeva NM; Ataullakhanov FI
    Int J Hematol; 2014; 99(5):588-96. PubMed ID: 24609767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients.
    Junqueira DR; Perini E; Penholati RR; Carvalho MG
    Cochrane Database Syst Rev; 2012 Sep; (9):CD007557. PubMed ID: 22972111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major bleeding risks of different low-molecular-weight heparin agents: a cohort study in 12 934 patients treated for acute venous thrombosis.
    van Rein N; Biedermann JS; van der Meer FJM; Cannegieter SC; Wiersma N; Vermaas HW; Reitsma PH; Kruip MJHA; Lijfering WM
    J Thromb Haemost; 2017 Jul; 15(7):1386-1391. PubMed ID: 28440008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thrombotic events in severe and critically COVID-19 patients despite high dose prophylactic low-molecular-weight heparin.
    Visser C; Sprenger RA; van den Bout HJ; Boer DP; El Moussaoui R; den Hollander JG
    Thromb Update; 2020 Dec; 1():100006. PubMed ID: 38620665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.